Search  Login Impressum Data-Privacy Contact
Logo
  • Other Meetings
  • Network Services
    Management Infocenter Informatics Registries
  • Leukemias
    ALL AML CML CLL CMPD MDS
  • Diagnostics
    Diagnostics WP10 Course March 2013 Cytogenetics MRD Next generation sequencing
  • Treat. Research
    SCT Supportive Care Quality of Life and Late Effects
  • Physicians
    Treatment Adverse Reactions Diagnosis Contact Recommendations Links Dates / Meetings
  • Trials
    Structure Workshops Legislation Links
  • ALL
  • AML
    • Project Info
    • Contact
    • Study Groups
    • Research
    • APL
      • APL-recommendations
      • APL-Register
    • AML-Information
    • AML PRT score
    • Publications
    • Dates / Meetings
    • Minutes
    • Links
    • Recommendations
  • CML
  • CLL
  • CMPD
  • MDS
  1. ELN
  2. Leukemias
  3. AML
  4. APL
  5. APL-recommendations
  6. ·

European recommendation for APL

European recommendation for salvage therapy of relapsed acute promyelocytic leukemia (APL) including arsenic trioxide (ATO)

Author: PD Dr. Eva Lengfelder, University of Mannheim/Germany

Guidelines

application/pdf Recommendations: Relapsed APL (312KB)
Recommendations_relapsed_APL_12122007

About us

The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care and cure.

Lastest Posts

Links

  • CML-Collaboration
  • Cytogenetics
  • SCT
  • Supportive Care

Kontakt-Info

ELN-Foundation
Im Langgewann 45
69469 Weinheim, Germany

Hehlmann.ELN@gmail.com

www.elnfoundation.org

© 2004-2024 ELN-Foundation - All Rights Reserved.
  • Data-Privacy
  • |
  • Impressum
  • |
  • Contact